Search by Drug Name or NDC

    NDC 00310-7442-02 EVUSHELD Details

    EVUSHELD

    EVUSHELD is a KIT in the VACCINE category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is .

    Product Information

    NDC 00310-7442
    Product ID 0310-7442_1bd44ff2-6f1b-42cb-a123-b8363c735b7e
    Associated GPIs 19509902802020
    GCN Sequence Number 082896
    GCN Sequence Number Description tixagevimab/cilgavimab VIAL 150-150 MG INTRAMUSC
    HIC3 W5D
    HIC3 Description ANTIVIRAL MONOCLONAL ANTIBODIES
    GCN 51673
    HICL Sequence Number 047712
    HICL Sequence Number Description TIXAGEVIMAB/CILGAVIMAB
    Brand/Generic Brand
    Proprietary Name EVUSHELD
    Proprietary Name Suffix n/a
    Non-Proprietary Name AZD7442
    Product Type VACCINE
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name AstraZeneca Pharmaceuticals LP
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category EMERGENCY USE AUTHORIZATION
    Application Number n/a
    Listing Certified Through 2023-12-31

    Package

    NDC 00310-7442-02 (00310744202)

    NDC Package Code 0310-7442-02
    Billing NDC 00310744202
    Package 1 KIT in 1 PACKAGE (0310-7442-02) * 1.5 mL in 1 VIAL (0310-1061-01) * 1.5 mL in 1 VIAL (0310-8895-01)
    Marketing Start Date 2021-12-08
    NDC Exclude Flag N
    Pricing Information N/A